Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer’s disease
✍ Scribed by M. W. Weiner
- Book ID
- 107669800
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 42 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1279-7707
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Alzheimer's disease (AD) differs from other forms of dementia in its relation to amyloid β peptide (Aβ). Aβ, a proteolytic product of amyloid precursor proteins (APP), has a toxic effect on neuronal cells, which involves perturbation of their Ca^2+^ homeostasis. This effect implies that
Early and differential diagnosis of Alzheimer's disease (AD) is a problem that puzzled many doctors. Reliable markers in easy-assembling samples are of considerable clinical diagnostic value. In this work, laser Raman spectroscopy (LRS) was developed a new method that potentially allows early and di